Neurobiology of Aging
Volume 30, Issue 10 , Pages 1574-1586 , October 2009

Mitochondrial dysfunction: An early event in Alzheimer pathology accumulates with age in AD transgenic mice

  • S. Hauptmann

      Affiliations

    • Department of Pharmacology, ZAFES, Biocenter, University of Frankfurt, 60438 Frankfurt, Germany
    • Both authors contributed equally to this work.
    • ,
  • I. Scherping

      Affiliations

    • Department of Pharmacology, ZAFES, Biocenter, University of Frankfurt, 60438 Frankfurt, Germany
    • Both authors contributed equally to this work.
    • ,
  • S. Dröse

      Affiliations

    • Molecular Bioenergetics Group, Medical School, Centre of Excellence Frankfurt “Macromolecular Complexes”, University of Frankfurt, Theodor Stein Kai 7, 60590 Frankfurt/M., Germany
    • ,
  • U. Brandt

      Affiliations

    • Molecular Bioenergetics Group, Medical School, Centre of Excellence Frankfurt “Macromolecular Complexes”, University of Frankfurt, Theodor Stein Kai 7, 60590 Frankfurt/M., Germany
    • ,
  • K.L. Schulz

      Affiliations

    • Department of Pharmacology, ZAFES, Biocenter, University of Frankfurt, 60438 Frankfurt, Germany
    • ,
  • M. Jendrach

      Affiliations

    • Kinematic Cell Research Group, Institute for Cell Biology and Neuroscience, JW Goethe University, Max-von-Laue-Strasse 9, D-60438 Frankfurt/Main, Germany
    • ,
  • K. Leuner

      Affiliations

    • Department of Pharmacology, ZAFES, Biocenter, University of Frankfurt, 60438 Frankfurt, Germany
    • ,
  • A. Eckert

      Affiliations

    • Neurobiology Research Laboratory, Psychiatric University Clinic, 4025 Basel, Switzerland
    • ,
  • W.E. Müller

      Affiliations

    • Department of Pharmacology, ZAFES, Biocenter, University of Frankfurt, 60438 Frankfurt, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 6979829373; fax: +49 6979829374.

Received 25 January 2007 ,Revised 3 December 2007 ,Accepted 5 December 2007.

References 

  1. Aleardi AM, Benard G, Augereau O, Malgat M, Talbot JC, Mazat JP, et al. Gradual alteration of mitochondrial structure and function by beta-amyloids: importance of membrane viscosity changes, energy deprivation, reactive oxygen species production, and cytochrome c release. J. Bioenerg. Biomembr. 2005;37(4):207–225
  2. Baracca A, Sgarbi G, Solaini G, Lenaz G. Rhodamine 123 as a probe of mitochondrial membrane potential: evaluation of proton flux through F(0) during ATP synthesis. Biochim. Biophys. Acta. 2003;1606(1–3):137–146
  3. Blanchard V, Moussaoui S, Czech C, Touchet N, Bonici B, Planche M, et al. Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice. Exp. Neurol. 2003;184(1):247–263
  4. Blass JP, Gibson GE, Hoyer S. The role of the metabolic lesion in Alzheimer's disease. J. Alzheimers Dis. 2002;4(3):225–232
  5. Blass JP. Cerebrometabolic abnormalities in Alzheimer's dosease. Neurol. Res. 2003;25(6):556–566
  6. Bosetti F, Brizzi F, Barogi S, Mancuso M, Siciliano G, Tendi EA, et al. Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease. Neurobiol. Aging. 2002;23(3):371–376
  7. Canevari L, Clark JB, Bates TE. beta-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria. FEBS Lett. 1999;457(1):131–134
  8. Cardoso SM, Proenca MT, Santos S, Santana I, Oliveira CR. Cytochrome c oxidase is decreased in Alzheimer's disease platelets. Neurobiol. Aging. 2004;25(1):105–110
  9. Caspersen C, Wang N, Yao J, Sosunov A, Chen X, Lustbader JW, et al. Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J. 2005;19(14):2040–2041
  10. Cavazzoni M, Barogi S, Baracca A, Parenti CG, Lenaz G. The effect of aging and an oxidative stress on peroxide levels and the mitochondrial membrane potential in isolated rat hepatocytes. FEBS Lett. 1999;449(1):53–56
  11. Chagnon P, Betard Robitaille Y, Cholette A, Gauvreau D. Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases. Neuroreport. 1995;6(5):711–715
  12. Crouch SP, Kozlowski R, Slater KJ, Fletcher J. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J. Immunol. Methods. 1993;160(1):81–88
  13. David DC, Hauptmann S, Scherping I, Schuessel K, Keil U, Rizzu P, et al. Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice. J. Biol. Chem. 2005;280(25):23802–23814
  14. De la Torre J, Aliev G, Perry G. Drug therapy in Alzheimer's disease. N. Engl. J. Med. 2004;351(18):1911–1913
  15. Dykens JA. Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated Ca2+ and Na+: implications for neurodegeneration. J. Neurochem. 1994;63(2):584–591
  16. Eckert A, Steiner B, Marques C, Leutz S, Romig H, Haass C, et al. Elevated vulnerability to oxidative stress-induced cell death and activation of caspase-3 by the Swedish amyloid precursor protein mutation. J. Neurosci. Res. 2001;64(2):183–192
  17. Eckert A, Keil U, Marques CA, Bonert A, Frey C, Schussel K, et al. Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease. Biochem. Pharmacol. 2003;66(8):1627–1634
  18. Fernandez-Vizarra P, Fernandez AP, Castro-Blanco S, Serrano J, Bentura ML, Martinez-Murillo R, et al. Intra- and extracellular Abeta and PHF in clinically evaluated cases of Alzheimer's disease. Histol. Histopathol. 2004;19(3):823–844
  19. Hauptmann S, Keil U, Scherping I, Bonert A, Eckert A, Müller WE. Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease. Exp. Gerontol. 2006;41(7):668–673
  20. Henlsey K, Carney JM, Mattson MP, Aksenova M, Harris M, Wu JF, et al. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 1994;91(8):3270–3274
  21. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, et al. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 2001;21(9):3017–3023
  22. Hoyer S. Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update. Exp. Gerontol. 2000;35(9/10):1363–1372
  23. Jendrach M, Pohl S, Voth M, Kowald A, Hammerstein P, Bereiter-Hahn J. Morpho-dynamic changes of mitochondria during ageing of human endothelial cells. Mech. Age. Dev. 2005;126(6/7):813–821
  24. Keil U, Bonert A, Marques CA, Scherping I, Wayermann J, Strosznajder JB, et al. Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis. J. Biol. Chem. 2004;279(48):503110–550320
  25. Kish SJ, Bergeron C, Rajput A, Dozic S, Mastrogiacomo F, Chang LJ, et al. Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 1992;59(2):776–779
  26. Kitamura Y, Shimohama S, Kamoshima W, Ota T, Matsuoka Y, Nomura Y, et al. Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease. Brain Res. 1998;780(2):260–269
  27. LaFerla FM. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat. Rev. Neurosci. 2002;3(11):862–872
  28. Leuner K, Hauptmann S, Abdel-Kader R, Scherping I, Keil U, Strosznajder JB, et al. Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease?. Antiox Redox Signal. 2007;9(10):1659–1675
  29. Leutner S, Eckert A, Müller WE. ROS generation and antioxidant enzyme activites in the aging brain. J. Neurol. Transm. 2001;108:955–967
  30. Leutz S, Steiner B, Marques CA, Haass C, Muller WE, Eckert A. Reduction of trophic support enhances apoptosis in PC12 cells expressing Alzheimer's APP mutation and sensitises cells to staurosporine-induced cell death. J. Mol. Neurosci. 2002;18(3):189–201
  31. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951;193(1):265–275
  32. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, et al. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science. 2004;304(5669):448–452
  33. Moreira PI, Santos MS, Oliveira CR. Alzheimer's Disease: A Lesson from Mitochondrial Dysfunction. Antioxid. Redox Signal. 2007;9(10):1621–1630
  34. MacGibbon GA, Lawlor PA, Sirimanne ES, Walton MR, Connor B, Young D, et al. Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus. Brain Res. 1997;750(1/2):223–234
  35. Mancuso M, Filosto M, Bosetti F, Ceravolo R, Rocchi A, Tognoni G, et al. Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease. Exp. Neurol. 2003;182(2):421–426
  36. Mancuso M, Coppedè F, Murri L, Siciliano G. Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality?. Antioxid. Redox Signal. 2007;9(10):1631–1646
  37. Marques CA, Keil U, Bonert A, Steiner B, Haass C, Muller WE, et al. Neurotoxic mechanism caused by the Alzheimer's disease-linked Swedish amyloid precursor protein mutation: oxidative stress, caspases, and the JNK pathway. J. Biol. Chem. 2003;278(30):28294–28302
  38. Martinez M, Ferrandiz ML, De Juan E, Miquel J. Age-related changes in gluathione and lipid peroxide content in mouse synaptic mitochondria: relationship to cytochrome c oxidase decline. Neurosci. Lett. 1994;170(1):121–124
  39. Mattson MP. Pathways towards and away from Alzheimer's disease. Nature. 2004;430:631–639
  40. Müller WE, Kirsch C, Eckert GP. Membrane disordering effects of ß-amyloid peptides. Biochem. Soc. Trans. 2001;(Pt 4):617–623
  41. Nagy ZS, Esiri M. Apoptosis-related protein expression in the hippocampus in Alzheimer's disease. Neurobiol. Aging. 1997;18(6):565–571
  42. Nakahara H, Kanno T, Inai Y, Utsumi K, Hiramatsu M, Mori A, et al. Mitochondrial dysfunction in the senescence accelerated mouse (SAM). Free Radic. Biol. Med. 1998;24(1):85–92
  43. Navarro A, Gomez C, Lopez-Cepero JM, Boveris A. Beneficial effects of moderate exercise on mice aging: survival, behavior, oxidative stress, and mitochondrial electron transfer. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004;286(5):R505–R511
  44. Navarro A, Gomez C, Sanchez-Pino MJ, Gonzalez H, Bandez MJ, Boveris AD, et al. Vitamin E at high doses improves survival, neurological performance, and brain mitochondrial function in aging male mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005;289(5):R1392–R1399
  45. Pierrot N, Santos SF, Feyt C, Morel M, Brion JP, Octave JN. Calcium-mediated transient phosphorylation of tau and amyloid precursor protein followed by intraneuronal amyloid-beta accumulation. J. Biol. Chem. 2006;281(52):39907–39914
  46. Rasmussen UF, Rasmussen HN. Human quadriceps muscle mitochondria: a functional characterization. Mol. Cell Biochem. 2000;208(1/2):37–44
  47. Rodrigo J, Fernandez-Vizarra P, Castro-Blanco S, Bentura ML, Nieto M, Gomez-Isla T, et al. Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice. Neuroscience. 2004;128(1):3–89
  48. Santos JH, Mandavilli BS, Van Houten B. Measuring oxidative mtDNA damage and repair using quantitative PCR. Methods Mol. Biol. 2002;197:159–176
  49. Schägger H, de Coo R, Bauer MF, Hofmann S, Godinot C, Brandt U. Significance of respirasomes for the assembly/stability of human respiratory chain complex I. J. Biol. Chem. 2004;279(35):36349–36353
  50. Schuessel K, Schafer S, Bayer TA, Czech C, Pradier L, Muller-Spahn F, et al. Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice. Neurobiol. Dis. 2005;18(1):89–99
  51. Selkoe DJ. Images of neuroscience. Alzheimer's disease: from genes to pathogenesis. Am. J. Psychiatry. 1997;154(9):1198
  52. Su JH, Deng G, Cotman CW. Bax protein expression is increased in Alzheimer's brain: correlations with DNA damage. Bcl-2 expression and brain pathology. J. Neuropathol. Exp. Neurol. 1997;56:86–93
  53. Wittig I, Braun H-P, Schägger H. Blue native PAGE. Nature Protoc. 2006;1:416–428

PII: S0197-4580(07)00467-8

doi: 10.1016/j.neurobiolaging.2007.12.005

Neurobiology of Aging
Volume 30, Issue 10 , Pages 1574-1586 , October 2009

Article Tools

* Image Usage & Resolution